NNC 711 - CAS 145645-62-1
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
GABA Receptor
NNC 711 is a GABA uptake inhibitor by GAT-1 with IC50 values of 0.04, 171, 1700 and 622 μM for hGAT-1, rGAT-2, hGAT-3 and hBGT-1. NNC 711 is an anticonvulsantagent.
≥99% by HPLC
1,2,5,6-Tetrahydro-1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-3-pyridinecarboxylic acid hydrochloride
Canonical SMILES:
1.Different mechanisms regulate IPSC kinetics in early postnatal and juvenile hippocampal granule cells.
Draguhn A;Heinemann U J Neurophysiol. 1996 Dec;76(6):3983-93.
1. Monosynaptic inhibitory postsynaptic currents (IPSCs) were recorded from early postnatal and juvenile dentate granule cells in rat brain slices at room temperature. The focally evoked currents were mediated by gamma-aminobutyric acid-A (GABAA) receptors. 2. IPSCs were characterized by a steep rising phase and a slower, monoexponential decay time course. The decay time constant was potential dependent and average values ranged from 33 ms at a holding potential of -60 mV to 58 ms at a holding potential of +40 mV. 3. IPSCs were studied in tissue from animals between postnatal day (p) 3 and p25. All kinetic parameters as well as the mean current amplitude were unchanged during this ontogenetic period. 4. In juvenile granule cells from animals aged 13-16 days, addition of the GABA uptake blocker (R)-N-[4,4-bis (3-methyl-2-thienyl) but-3-en1-yl] nipecotic acid (tiagabine) (10 microM) prolonged the decaying phase of the IPSCs. The current decay remained monoexponential but the time constant increased to 250% of control values. Mean current amplitudes remained largely unchanged. 5. In contrast, tiagabine had no effect on IPSCs in early postnatal tissuĕ. The decay time constant remained unchanged in cells recorded from animals aged p4-p6.
2.GABA transporters regulate tonic and synaptic GABA
Moldavan M;Cravetchi O;Allen CN J Neurophysiol. 2017 Dec 1;118(6):3092-3106. doi: 10.1152/jn.00194.2017. Epub 2017 Aug 30.
GABA is a principal neurotransmitter in the hypothalamic suprachiasmatic nucleus (SCN) that contributes to intercellular communication between individual circadian oscillators within the SCN network and the stability and precision of the circadian rhythms. GABA transporters (GAT) regulate the extracellular GABA concentration and modulate GABA;A; receptor (GABA;A;R)-mediated currents. GABA transport inhibitors were applied to study how GABA;A;R-mediated currents depend on the expression and function of GAT. Nipecotic acid inhibits GABA transport and induced an inward tonic current in concentration-dependent manner during whole cell patch-clamp recordings from SCN neurons. Application of either the selective GABA transporter 1 (GAT1) inhibitors NNC-711 or SKF-89976A, or the GABA transporter 3 (GAT3) inhibitor SNAP-5114, produced only small changes of the baseline current. Coapplication of GAT1 and GAT3 inhibitors induced a significant GABA;A;R-mediated tonic current that was blocked by gabazine. GAT inhibitors decreased the amplitude and decay time constant and increased the rise time of spontaneous GABA;A;R-mediated postsynaptic currents. However, inhibition of GAT did not alter the expression of either GAT1 or GAT3 in the hypothalamus.
3.Evaluation of GABA uptake in subcellular fractions of bovine frontal cortex and brainstem.
Höfner G;Wanner KT Neurosci Lett. 2004 Jun 24;364(1):53-7.
GABA uptake as well as the distribution of GAT-1, GAT-2 and GAT-3 were investigated in bovine brain membrane fractions. GABA uptake was characterised by kinetic constants and IC50-values for a series of known inhibitors in subcellular fractions of frontal cortex and brainstem obtained by subsequent centrifugations on sucrose gradients. Additionally, the immunoreactivity for rGAT-1, rGAT-2 and rGAT-3 antibodies was studied in these fractions. The pharmacological profile for GABA uptake inhibition as well as results from immunoblotting indicated that GABA uptake in a selected subcellular fraction of frontal cortex (P2B) is almost exclusively due to GAT-1 whereas GABA uptake performed with a selected subcellular fraction of brainstem (P2A) in the presence of NNC 711 is mainly attributable to GAT-3.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related GABA Receptor Products

CAS 325715-02-4 Indiplon

(CAS: 325715-02-4)

Indiplon acts as a high-affinity positive and orally active allosteric modulator of the GABAA receptor (Ki=1.2 nM in rat frontal cortex and Ki=1.7 nM and in cer...

CAS 157013-85-9 U 89843A

U 89843A
(CAS: 157013-85-9)

U 89843A is a positive allosteric modulator of GABAA receptors. U 89843A potentiates GABA-induced Cl- currents in the α1β2γ2, α3β2γ2 and α6β2γ2 GABAA receptors....

CAS 164025-33-6 PWZ-029

(CAS: 164025-33-6)

PWZ-029, a benzodiazepine derivative, has been found to be a GABAA receptors inverse agonist that could probably improve memory and exhibit sedative effects at ...

CAS 40709-69-1 (-)-Bicuculline methiodide

(-)-Bicuculline methiodide
(CAS: 40709-69-1)

(-)-Bicuculline methiodide is the methiodide salt of (+)-bicuculline, which is a potent antagonist of GABAA receptors.

CAS 160296-13-9 SB 205384

SB 205384
(CAS: 160296-13-9)

SB 205384 is a GABAA receptor modulator. SB 205384 potentiates α6, α3 and α5-subunit-containing receptors (EC50 = 280, 695 and 730 nM, respectively). It exhibit...

CAS 194098-25-4 CP-409092

(CAS: 194098-25-4)

CP-409092 is a GABA(A) partial agonist developed for the treatment of General Anxiety Disorder (GAD) and presents an interesting phenomenon of human pharmacokin...

CAS 38398-32-2 Ganaxolone

(CAS: 38398-32-2)

Ganaxolone is a positive allosteric modulator of GABAA receptors with anticonvulsive anxiolytic properties. Ganaxolone enhances GABA-evoked chloride currents in...

CAS 1216792-30-1 ZK 93426 hydrochloride

ZK 93426 hydrochloride
(CAS: 1216792-30-1)

ZK 93426 hydrochloride is a potent, selective and competitive benzodiazepine receptor antagonist (IC50 = 0.4 and 0.7 nM for inhibition of [3H]-flunitrazepam bin...

CAS 184845-18-9 NNC 05-2090 hydrochloride

NNC 05-2090 hydrochloride
(CAS: 184845-18-9)

NNC052090 is a GABA uptake inhibitor that displays selectivity for BGT-1 (mGAT-2) transporters.

CAS 1236105-75-1 PHP 501 trifluoroacetate

PHP 501 trifluoroacetate
(CAS: 1236105-75-1)

PHP 501 trifluoroacetate is potent GABAA antagonist (Ki = 0.0028 μM at rat GABAA receptors; IC50 = 0.024 μM at human α1β2γ2 GABAA-expressing tsA201 cells), with...

CAS 157604-55-2 (S)-SNAP 5114

(S)-SNAP 5114
(CAS: 157604-55-2)

(S)-SNAP 5114 is a GABA transport inhibitor, displaying selectivity for GAT-3 and GAT-2 (IC50 = 5, 21 and 388 μM for hGAT-3, rGAT-2 and hGAT-1, respectively). (...

CAS 69308-37-8 (R)-baclofen

(CAS: 69308-37-8)

(R)-baclofen a selective GABAB agonist.

CAS 164025-44-9 PZ-II-029

(CAS: 164025-44-9)

PZ-II-029,a pyrazoloquinolinone, was reported as the first postitive modulator of GABAA α6β3γ2 subtype functionally selective ligands to date.

CAS 3569-10-6 Valerenic acid

Valerenic acid
(CAS: 3569-10-6)

Valerenic acid is a positive allosteric modulator of GABAA receptors displaying selectivity for receptors containing β2 or β3 subunits. Valerenic acid exhibits ...

CAS 91917-65-6 Ro 15-4513

Ro 15-4513
(CAS: 91917-65-6)

Ro 15-4513, a high affinity benzodiazepine ligand, acts as a competitive antagonist, and can therefore be an antidote to the acute impairment caused by alcohol....

CAS 252977-51-8 TPA023

(CAS: 252977-51-8)

TPA023, also called as MK-0777, is a subtype-selective, mixed agonist-antagonist at GABAA receptor with anxiolytic and anticonvulsant effects.

CAS 114012-12-3 Phaclofen

(CAS: 114012-12-3)

Phaclofen, a phosphonic acid derivative of Baclofen, is a selective GABAB antagonist.

CAS 39069-52-8 GS 39783

GS 39783
(CAS: 39069-52-8)

GS 39783 is an allosteric positive modulator of GABAB receptors, decreases cocaine self-administration, blocks the rewarding properties of nicotine and produces...

CAS 733717-87-8 SCH-50911

(CAS: 733717-87-8)

CH-50911 is a selective GABA-B antagonist with IC50 value of 1.1 μM. It is developed by Schering-Plough Corporation. CH-50911 is often used in pharmacology rese...

CAS 60252-41-7 (±)-Nipecotic acid

(±)-Nipecotic acid
(CAS: 60252-41-7)

(±)-Nipecotic acid is a nonselective GAT inhibitor that also induces GABA release through a process termed 'heteroexchange. IC50 = 8, 38, 106 and 2370 μM for hG...

Chemical Structure

CAS 145645-62-1 NNC 711

Quick Inquiry

Verification code

Featured Items